PHI with Primary Biliary Cholangitis (PBC)
How does this condition affect your private health insurance?
Primary Biliary Cholangitis (PBC), formerly Primary Biliary Cirrhosis, is a chronic autoimmune liver disease. It slowly destroys the small bile ducts within the liver, impairing bile flow and leading to its accumulation. This can cause inflammation, scarring, and eventually cirrhosis and liver failure. Symptoms, often insidious, include profound fatigue, intense pruritus (itching), and jaundice, though many individuals are asymptomatic at diagnosis. Diagnosis typically involves detecting elevated liver enzymes, particularly alkaline phosphatase, and specific anti-mitochondrial antibodies (AMA). Treatment focuses on slowing disease progression and managing symptoms, with ursodeoxycholic acid (UDCA) being the cornerstone therapy. Regular monitoring is crucial to manage complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms can be subtle and develop over weeks to months, often leading to diagnosis during routine tests.
Duration of Illness (Lifetime)
A chronic, progressive disease lasting a lifetime, requiring ongoing management.
Cost of Treatment (Initial)
Initial diagnostic tests (blood work, imaging, possibly biopsy) and commencement of lifelong medication (e.g., Ursodeoxycholic acid).
Cost of Treatment (Lifetime)
Significant, involving lifelong medication, regular specialist visits, monitoring for complications, and potentially very high costs if a liver transplant is required.
Mortality Rate
Variable; significantly reduced with timely treatment, but still a risk due to complications like liver failure or associated conditions, especially in advanced stages.
Risk of Secondary Damages
High, including cirrhosis, liver failure, portal hypertension, osteopenia/osteoporosis, malabsorption, vitamin deficiencies, severe fatigue, pruritus, and increased risk of hepatocellular carcinoma.
Probability of Full Recovery
Extremely low for full, natural recovery of the liver. Treatment manages the disease but doesn't cure it. Liver transplantation can replace the diseased liver, but it's not a recovery of the original organ.
Underlying Disease Risk
Moderate to high. PBC is frequently associated with other autoimmune diseases such as Sjögren's syndrome, autoimmune thyroiditis, rheumatoid arthritis, and scleroderma.